A new study has shown that non-cancerous cells positioned close to tumours can affect how cancer responds to treatment.

We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

Hormone replacement therapy taken at age 50 for up to 5 years only modestly increases the risk of breast cancer, even for women with a strong family history of the disease, according to a new risk ...

The Breast Cancer Now Toby Robins Research Centre at the ICR receives funding from the charity Breast Cancer Now, and was opened in 1999 by Breast Cancer Now's Patron, HRH The Prince of Wales. The ...

Scientists at The Institute of Cancer Research, London, have found a way to identify people with inflammatory bowel disease (IBD) who are at the highest risk of developing bowel cancer. IBD includes ...

The goal of our laboratory is to improve the treatment and survival of children with neuroblastoma, medulloblastoma and rhabdomyosarcoma, three paediatric solid tumours in which high-risk patient ...

We are a world-leading cancer research institute, a charity, and a member institution of the University of London. Public donations and clinical partnerships are helping us to make the discoveries ...

The Institute of Cancer Research believes that animal research is essential to understand how cancers develop and behave within a whole organism, and how to treat it effectively. We use animal studies ...

Prostate cancer that has become resistant to hormone therapy could be treated using a new drug that is currently in clinical trials for ovarian and bile duct cancer, according to research published in ...